Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Literature
1.
Schmittinger CA, Torgersen C, Luckner G, Schröder DCH, Lorenz I, Dünser MW (2012) Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 38:950–958. doi:10.​1007/​s00134-012-2531-2 PubMedCrossRef
2.
Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J; CORTICUS Study Group (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124CrossRef
3.
Moreno R, Sprung CL, Annane D, Chevret S, Briegel J, Keh D, Singer M, Weiss YG, Payen D, Cuthbertson BH, Vincent JL (2011) Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study. Intensive Care Med 37:1765–1772PubMedCrossRef
4.
Sligl WI, Milner DA Jr, Sundar S, Mphatswe W, Majumdar SR (2009) Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis 49:93–101PubMedCrossRef
5.
Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU (2009) Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 301:2362–2375PubMedCrossRef
Metadata
Title
Adverse cardiac events during catecholamine therapy: a role for hydrocortisone?
Authors
A. Salvadori
P. Pasquier
A. Jarrassier
J. Renner
S. Merat
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 10/2012
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-012-2663-4

Other articles of this Issue 10/2012

Intensive Care Medicine 10/2012 Go to the issue

Correspondence

Life-threatening endobronchial myiasis

Original

ICU admission characteristics and mortality rates among elderly and very elderly patients

Original

Effects of propofol on sleep quality in mechanically ventilated critically ill patients: a physiological study

Experimental

Respiratory dialysis with an active-mixing extracorporeal carbon dioxide removal system in a chronic sheep study

Correspondence

Response to Salvadori et al.: adverse cardiac events during catecholamine therapy: a role for hydrocortisone?

Editorial

Noninvasive ventilation for weaning in hypoxemic respiratory failure: not ready for prime time